Special Survey on PD Patients With Renal Dysfunction

CompletedOBSERVATIONAL
Enrollment

107

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

September 30, 2008

Conditions
Parkinson Disease
Trial Locations (98)

Unknown

Boehringer Ingelheim Investigational Site, Asahikawa

Boehringer Ingelheim Investigational Site, Azumino

Boehringer Ingelheim Investigational Site, Chūō

Boehringer Ingelheim Investigational Site, Fuji

Boehringer Ingelheim Investigational Site, Fujinomiya

Boehringer Ingelheim Investigational Site, Fujisaki

Boehringer Ingelheim Investigational Site, Fukaya

Boehringer Ingelheim Investigational Site, Fukui

Boehringer Ingelheim Investigational Site, Fukuoka

Boehringer Ingelheim Investigational Site, Gifu

Boehringer Ingelheim Investigational Site, Hachiōji

Boehringer Ingelheim Investigational Site, Hamamatsu

Boehringer Ingelheim Investigational Site, Himeji

Boehringer Ingelheim Investigational Site, Hiroshima

Boehringer Ingelheim Investigational Site, Ichinoseki

Boehringer Ingelheim Investigational Site, Iga

Boehringer Ingelheim Investigational Site, Iida

Boehringer Ingelheim Investigational Site, Iijima

Boehringer Ingelheim Investigational Site, Ina

Boehringer Ingelheim Investigational Site, Inazawa

Boehringer Ingelheim Investigational Site, Isehara

Boehringer Ingelheim Investigational Site, Isesaki

Boehringer Ingelheim Investigational Site, Iwamizawa

Boehringer Ingelheim Investigational Site, Kagoshima

Boehringer Ingelheim Investigational Site, Kajiki

Boehringer Ingelheim Investigational Site, Kanoya

Boehringer Ingelheim Investigational Site, Kashiwazaki

Boehringer Ingelheim Investigational Site, Kawagoe

Boehringer Ingelheim Investigational Site, Kawasaki

Boehringer Ingelheim Investigational Site, Koga

Boehringer Ingelheim Investigational Site, Koga

Boehringer Ingelheim Investigational Site, Komae

Boehringer Ingelheim Investigational Site, Koshigaya

Boehringer Ingelheim Investigational Site, Kōriyama

Boehringer Ingelheim Investigational Site, Kurashiki

Boehringer Ingelheim Investigational Site, Kyoto

Boehringer Ingelheim Investigational Site, Maebashi

Boehringer Ingelheim Investigational Site, Marugame

Boehringer Ingelheim Investigational Site, Matsudo

Boehringer Ingelheim Investigational Site, Matsumoto

Boehringer Ingelheim Investigational Site, Miki

Boehringer Ingelheim Investigational Site, Mito

Boehringer Ingelheim Investigational Site, Miyazaki

Boehringer Ingelheim Investigational Site, Miyoshi

Boehringer Ingelheim Investigational Site, Mooka

Boehringer Ingelheim Investigational Site, Morioka

Boehringer Ingelheim Investigational Site, Morohongō

Boehringer Ingelheim Investigational Site, Nagahama

Boehringer Ingelheim Investigational Site, Nagakute

Boehringer Ingelheim Investigational Site, Nagasaki

Boehringer Ingelheim Investigational Site, Nagoya

Boehringer Ingelheim Investigational Site, Nanao

Boehringer Ingelheim Investigational Site, Nangōku

Boehringer Ingelheim Investigational Site, Narita

Boehringer Ingelheim Investigational Site, Nishinomiya

Boehringer Ingelheim Investigational Site, Okayama

Boehringer Ingelheim Investigational Site, Okinawa

Boehringer Ingelheim Investigational Site, Osaka

Boehringer Ingelheim Investigational Site, Ōgaki

Boehringer Ingelheim Investigational Site, Ōita

Boehringer Ingelheim Investigational Site, Ōkawa

Boehringer Ingelheim Investigational Site, Ōnojō

Boehringer Ingelheim Investigational Site, Ōshū

Boehringer Ingelheim Investigational Site, Sado

Boehringer Ingelheim Investigational Site, Sagamihara

Boehringer Ingelheim Investigational Site, Saitama

Boehringer Ingelheim Investigational Site, Sanjō

Boehringer Ingelheim Investigational Site, Sapporo

Boehringer Ingelheim Investigational Site, Sekigahara

Boehringer Ingelheim Investigational Site, Shimotsuke

Boehringer Ingelheim Investigational Site, Shingū

Boehringer Ingelheim Investigational Site, Shūnan

Boehringer Ingelheim Investigational Site, Suita

Boehringer Ingelheim Investigational Site, Takasago

Boehringer Ingelheim Investigational Site, Takatsuki

Boehringer Ingelheim Investigational Site, Togitsu

Boehringer Ingelheim Investigational Site, Tokyo Adachi-ku

Boehringer Ingelheim Investigational Site, Tokyo Bunkyo-ku

Boehringer Ingelheim Investigational Site, Tokyo Chiyoda-ku

Boehringer Ingelheim Investigational Site, Tokyo Itabashi-ku

Boehringer Ingelheim Investigational Site, Tokyo Meguro-ku

Boehringer Ingelheim Investigational Site, Tokyo Ota-ku

Boehringer Ingelheim Investigational Site, Tokyo Setagaya-ku

Boehringer Ingelheim Investigational Site, Tokyo Shibuya-ku

Boehringer Ingelheim Investigational Site, Tokyo Shinjuku-ku

Boehringer Ingelheim Investigational Site, Tokyo Suginami-ku

Boehringer Ingelheim Investigational Site, Toride

Boehringer Ingelheim Investigational Site, Toyoake

Boehringer Ingelheim Investigational Site, Tsukuba

Boehringer Ingelheim Investigational Site, Uki

Boehringer Ingelheim Investigational Site, Wakayama

Boehringer Ingelheim Investigational Site, Yamagata

Boehringer Ingelheim Investigational Site, Yamaguchi

Boehringer Ingelheim Investigational Site, Yokohama

Boehringer Ingelheim Investigational Site, Yokosuka

Boehringer Ingelheim Investigational Site, Yonago

Boehringer Ingelheim Investigational Site, Yoshinogawa

Boehringer Ingelheim Investigational Site, Yufu

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00613756 - Special Survey on PD Patients With Renal Dysfunction | Biotech Hunter | Biotech Hunter